TP53 and myelodysplastic syndrome: In accordance to these studies, and although in our series only 5 patients were allografted, the three patients who had TP53 mutations died in less than one year after the MDS diagnosis, whereas the two patients without TP53 alterations are still alive after more than 3 years after diagnosis.